Archives

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis
About This Event
Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis
This presentation discusses the key screening tools and diagnostic algorithms associated with autosomal dominant polycystic kidney disease (ADPKD), including risk assessment tools to assess for rapid progression.
The Butcher’s Son
Virginia Beach, VA 23451 United States + Google Map
Featuring

Kimberly Means, PharmD, BCCCP, BSN, RN
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Kimberly Means, PharmD, BCCCP, BSN, RN, is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Means earned her B.S. in Nursing (BSN) and her Doctor of Pharmacy (PharmD) from Virginia Commonwealth University (VCU) in Richmond, Virginia. She completed a PGY-1 Pharmacy Practice Residency and a PGY-2 Critical Care Residency at VCU Health in Richmond, Virginia. Prior to joining Otsuka, she worked as a critical care nurse at VCU Health, a Critical Care Clinical Pharmacist at Henrico Doctors’ Hospital, and a Clinical Pharmacist in Surgical Services at VCU Health. During her time as a Clinical Assistant Professor at the VCU School of Pharmacy and VCU Health she served as a preceptor for pharmacy students and pharmacy residents. Dr Means is a Board Certified Critical Care Pharmacotherapy Specialist (BCCCP).

Michael Filsinger, MPA, PA-C
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.
Dr Kimberly Means and Michael Filsinger are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).